This is an old revision of the document!
Matinas BioPharma
Matinas BioPharma is an American biopharmaceutical company based in Bedminster, New Jersey.
Activities
Matinas is running clinical trials for MAT2203, a cryptococcal meningitis treatment, led by principal investigators David Boulware and David Meya.1)
External links
1)
Matinas BioPharma Nanotechnologies, Inc., & University of Minnesota. (2022, September 15). Encochleated Oral Amphotericin for Cryptococcal Meningitis Trial 3. ClinicalTrials.gov. https://web.archive.org/web/20230509041731/https://clinicaltrials.gov/ct2/show/NCT05541107